KB

Kalsadarahalli Basavarajaiah Sujatha

Active Director Director DIN 10587286
DIN 10587286 First appointment Apr 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Kalsadarahalli Basavarajaiah Sujatha

Data last updated:

Kalsadarahalli Basavarajaiah Sujatha is a Director at Marlen Pharmaceutical Private Limited (since 2024). The company operates in Pharma.

DIN 10587286
Primary Designation Director
Industry Pharma
First Appointment 10 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Apr 20242024Active

Board colleagues of Kalsadarahalli Basavarajaiah Sujatha

Directorship timeline

Open interactive timeline →
Marlen Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Kalsadarahalli Basavarajaiah Sujatha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kalsadarahalli Basavarajaiah Sujatha

Kalsadarahalli Basavarajaiah Sujatha currently holds 1 directorship: Marlen Pharmaceutical Private Limited (Director, since 10 Apr 2024).

Kalsadarahalli Basavarajaiah Sujatha was first appointed on 10 Apr 2024 as Director at Marlen Pharmaceutical Private Limited.

The current boards of Kalsadarahalli Basavarajaiah Sujatha's companies include Siddalingappa Basavaraju Kumar Swamy (Marlen Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available